Skip to content
Lower risk Drug recall · FDA · Published July 22, 2026

Micro Labs Dorzolamide/Timolol Eye Drops Recall: Broken Caps Cause Undeliverable Drops

Micro Labs USA recalls 2% Dorzolamide and 0.5% Timolol eye drops due to broken cap spikes causing undeliverable drops. Rx-only medication with specific lot number and expiration date.

🇺🇸 FDA recall #D-0730-2026DrugMicro Labs ›
✎ GovInfoNow plain-language explainer

Micro Labs USA recalls eye drops that may have broken cap spikes, making it impossible to deliver the medication. This affects prescription eye drops that could cause missed doses if the cap doesn't seal properly. Read more at govinfonow.com/recall/164198-micro-labs-dorzolamide-timolol-eye-drops-recall-broken-caps-cause.

Source Summary by GovInfoNow · govinfonow.com/recall/164198-micro-labs-dorzolamide-timolol-eye-drops-recall-broken-caps-cause · Updated August 17, 2026 · FDA enforcement record: FDA #D-0730-2026

Cite this page

“Micro Labs Dorzolamide/Timolol Eye Drops Recall: Broken Caps Cause Undeliverable Drops.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/164198-micro-labs-dorzolamide-timolol-eye-drops-recall-broken-caps-cause. Based on FDA recall #D-0730-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0730-2026%22&limit=1).

Micro Labs USA Inc. voluntarily recalled Dorzolamide HCl and Timolol Maleate Ophthalmic Solution on July 22, 2026, after the FDA announced defective container caps could prevent drops from being delivered. The Food and Drug Administration issued recall D-0730-2026 for the Class II product.

How to tell if you have it

  • Brand: Micro Labs
  • Product: Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle
  • NDC: 42571-147-26
  • Lot #: DLHU0031
  • Expiration Date: 06/30/2027

The hazard

The FDA reported multiple complaints of broken cap spikes and undeliverable drops for the recalled ophthalmic solution. The defective containers may prevent the medication from being dispensed correctly.

Context

GovInfoNow's records show other recent recalls include Apotex Desmopressin Nasal Spray on 2026-04-08 and Thea Pharma Similasan Eye Drops on 2026-04-23. A separate Thea Pharma iVIZIA Eye Drops recall was also announced on 2026-04-23.

How to tell if you have this one

Check for the lot number DLHU0031 on the bottle label. The product is a 10mL prescription eye drop bottle with 2% Dorzolamide and 0.5% Timolol Maleate.

  • Brand
    Micro Labs
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Cap Integrity

    Inspect the cap for broken spikes that prevent proper delivery of the medication.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 14 days after the firm started it.

1. Firm started the recall: Jul 22, 202612. FDA classified it Class II: Jul 24, 202623. Published in FDA’s Enforcement Report: Aug 5, 202634. Added to GovInfoNow: Aug 11, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is for defective caps that may cause undeliverable drops. If the cap is intact, it may be safe to use, but the manufacturer recommends checking for broken spikes.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0730-2026 (July 22, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0730-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA